Why invest in socially responsible cannabis?

Invest in cannabis

Invest in cannabis

Cannabis continues to be one of the fastest-growing industries globally. In the United States alone, 11 states have legalized cannabis completely. 37 other states have legalized it for medical use (with limits on THC content). It is predicted that the global market for cannabinoid-based pharmaceuticals will reach $50 billion by 2029.

Now is a great time to get involved with companies at the forefront of developing cannabinoid products. When you invest in cannabis, you invest in the future of naturally based pharmaceuticals.

The truth about cannabinoids

When we think about cannabis, the first thought that comes to mind is THC. This is the mind-altering chemical found in the cannabis plant and is the only known intoxicating cannabinoid. Cannabidiol (CBD) has also gained recent popularity for its medicinal purposes.

Historically there have been negative views on cannabinoids and cannabis-related products. However, opinions are changing, and research has begun demonstrating the amazing health benefits behind these products. The U.S. Food and Drug Administration (FDA) has recently approved several drugs that contain individual cannabinoids.

These drugs are used to treat a number of conditions, including rare forms of epilepsy, nausea and vomiting caused by cancer treatment, and loss of appetite and weight in people with HIV/AIDS.2 Now is a great time to invest in cannabis research to continue to provide products to people who need them most.

Why invest in cannabis?

When you invest in cannabis, you will contribute to a fast-growing market, allowing you to capitalize on this surge and see a faster return on your investments.

Cannabigerol (CBG), cannabigerolic acid (CBGA), and other rare cannabinoids are great for your health. CBG has been found to interact with the same receptors in the body as CBD, which may give it it’s anti-inflammatory effects. With these findings, we expect the CBG market to grow continually. Investors will benefit from participating in this industry and supporting socially responsible causes of medicine and food production.

We are open to partnerships and investments, helping us impact natural solutions to health conditions and more. If you are interested, contact us today.

Saba IqbalAuthor posts

Dr. Saba Iqbal is a contributing writer for BioMedican. She's a clinical pharmacist turned writer. Dr. Saba's education includes a doctoral degree in pharmacy (Pharm D) from the University of Sargodha, Pakistan. In search of a career that would take advantage of her medical and pharmaceutical skills, Dr. Saba found medical writing – a career path a few medical students consider. In her journey "from a medical bench to pen," she has worked with several startups for many years managing content on biotech products, pharmaceuticals, drugs, devices, and techniques. While keeping up with the latest trends in medical writing, she aims to use her writing skills to clearly communicate complex scientific, medical, and health information to the potential investor and general audience.

Comments are disabled.